Egypt
Orchidia Pharmaceutical Industries (Orchidia) is an outstanding Egyptian company specialized in the production of pharmaceutical ophthalmic products. It holds the second position in the Egyptian ophthalmic market with the highest growth rate. Orchidia operates its own manufacturing facility in Al-Obour city on a 6,000 M² footprint, which is one of the largest in the Middle East region, with a current production capacity of 35 million units.
Orchidia is certified with WHO-GMP implementation from Egyptian MOH and other countries of registration in the Middle East and Africa, ISO 9001, ISO 14001, and OHSAS. The company prioritizes maintaining and continually improving its Quality Management Systems (QMS) and Environmental Health and Safety (EHS) to meet the essential quality level and exceed the expectations of all stakeholders.
The company's current portfolio includes 35 ophthalmic drugs and 3 medical devices that have obtained the CE marked certificates. Moreover, Orchidia has a rich pipeline of 60 drugs in different ophthalmic drug forms.
Founded in 1993, Orchidia Pharmaceutical Industries operates in the Manufacturing and Pharmaceutical industries. Currently, there is no specific information available regarding the company's headquarters, last investment, or investors.
